Bevacizumab in advanced colorectal cancer: a challenge to the current paradigm
- PMID: 18824719
- DOI: 10.1200/JCO.2008.18.8060
Bevacizumab in advanced colorectal cancer: a challenge to the current paradigm
Comment on
-
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer.J Clin Oncol. 2008 Apr 20;26(12):2006-12. doi: 10.1200/JCO.2007.14.9898. J Clin Oncol. 2008. PMID: 18421053 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
